Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Watanabe, Takafumi ^a   Hashimoto, Toshihiro ^b   Sugino, Takashi ^a   Soeda, Shu ^a   Nishiyama, Hiroshi ^a   Morimura, Yutaka ^b   Yamada, Hidekazu ^a   Goodison, Steve ^c   Fujimori, Keiya ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Tsuboi Cancer Center Hospital   (Japan)

^c M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

1 integrin; IL 1 ; mesothelial cell; ovarian cancer; peritoneal dissemination

Indexed keywords

BETA1 INTEGRIN; INTERLEUKIN 1BETA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; MOUSE; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84862799412     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-5-7     Document Type: Article

References (34)

1. Cancer of the ovary. Cannistra SA, N Engl J Med 2004 351 2519 2529 10.1056/NEJMra041842 15590954 (Pubitemid 39603165)
2. Surgical management of women with ovarian cancer. Cooper A, DePriest P, Semin Oncol 2007 34 226 233 10.1053/j.seminoncol.2007.03.010 17560984 (Pubitemid 46874556)
3. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, Kimmig R, Rehbock J, Holzel D, Eur J Cancer 2002 38 2435 2445 10.1016/S0959-8049(02)00495-1 12460789 (Pubitemid 35387497)
4. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Niedbala MJ, Crickard K, Bernacki RJ, Exp Cell Res 1985 160 499 513 10.1016/0014-4827(85)90197-1 3899694 (Pubitemid 16251304)
5. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP, Am J Pathol 1999 154 1525 1537 10.1016/S0002-9440(10)65406-5 10329605 (Pubitemid 29226447)
6. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Burleson KM, Hansen LK, Skubitz AP, Clin Exp Metastasis 2004 21 685 697 16035613
7. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Strobel T, Cannistra SA, Gynecol Oncol 1999 73 362 367 10.1006/gyno.1999.5388 10366461 (Pubitemid 29272856)
8. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, Turkyilmaz MA, Salgia R, Yamada SD, Vande Woude GF, et al. Cancer Res 2007 67 1670 1679 10.1158/0008-5472.CAN-06-1147 17308108 (Pubitemid 46383393)
9. Distribution and variable expression of secretory pathway protein reticulocalbin in normal human organs and non-neoplastic pathological conditions. Fukuda T, Oyamada H, Isshiki T, Maeda M, Kusakabe T, Hozumi A, Yamaguchi T, Igarashi T, Hasegawa H, Seidoh T, Suzuki T, J Histochem Cytochem 2007 55 335 345 17189526 (Pubitemid 46481941)
10. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. McAlindon ME, Hawkey CJ, Mahida YR, Gut 1998 42 214 219 10.1136/gut.42.2.214 9536946 (Pubitemid 28212176)
11. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI, Genes Dev 2006 20 2527 2538 10.1101/gad.1455706 16980582 (Pubitemid 44396838)
12. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ, Neoplasia 1999 1 50 62 10.1038/sj.neo.7900005 10935470
13. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ, Clin Cancer Res 1996 2 1627 1636 9816342 (Pubitemid 126447459)
14. Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha. Stadlmann S, Raffeiner R, Amberger A, Margreiter R, Zeimet AG, Abendstein B, Moser PL, Mikuz G, Klosterhalfen B, Offner FA, Virchows Arch 2003 443 678 685 10.1007/s00428-003- 0867-2 12898248 (Pubitemid 37500149)
15. Binding of ovarian cancer cell to peritoneal mesothelium in vitro is partly mediated by beta 1 integrins. Strobel T, Tai YT, Cannistra SA, Proceedings of the American Association for Cancer Research 1998 39 497
16. A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. Catterall JB, Gardner MJ, Jones LM, Thompson GA, Turner GA, Cancer Lett 1994 87 199 203 10.1016/0304-3835(94)90223-2 7812941
17. Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Jones LM, Gardner MJ, Catterall JB, Turner GA, Clin Exp Metastasis 1995 13 373 380 7641421
18. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. Dejana E, Bertocchi F, Bortolami MC, Regonesi A, Tonta A, Breviario F, Giavazzi R, J Clin Invest 1988 82 1466 1470 10.1172/JCI113753 3262629
19. VCAM-1-, ELAM-1-, and ICAM-1-independent adhesion of melanoma cells to cultured human dermal microvascular endothelial cells. Lee KH, Lawley TJ, Xu YL, Swerlick RA, J Invest Dermatol 1992 98 79 85 10.1111/1523-1747.ep12495643 1370233
20. Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. Hussain MM, Kotz H, Minasian L, Premkumar A, Sarosy G, Reed E, Zhai S, Steinberg SM, Raggio M, Oliver VK, et al. J Clin Oncol 2003 21 4356 4363 10.1200/JCO.2003.04.136 14645425 (Pubitemid 46621812)
21. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group. Bookman MA, Darcy KM, Clarke-Pearson D, Boothby RA, Horowitz IR, J Clin Oncol 2003 21 283 290 10.1200/JCO.2003.10.104 12525520 (Pubitemid 46606157)
22. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Byzova TV, Kim W, Midura RJ, Plow EF, Exp Cell Res 2000 254 299 308 10.1006/excr.1999.4765 10640428 (Pubitemid 30080586)
23. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC, Gauldie J, Am J Pathol 2002 160 2285 2294 10.1016/S0002-9440(10)61176-5 12057931 (Pubitemid 34663419)
24. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T, Kidney Int 2002 61 570 578 10.1046/j.1523-1755.2002.00143.x 11849398 (Pubitemid 34102598)
25. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Muller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C, J Clin Oncol 1998 16 1861 1868 9586902 (Pubitemid 28234733)
26. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Holmdahl L, Ivarsson ML, Eur J Surg 1999 165 1012 1019 10.1080/110241599750007810 10595602 (Pubitemid 29529376)
27. Peritoneal membrane morphology and function. Nagy JA, Kidney Int Suppl 1996 56 2 11 8914047
28. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF, Cancer Res 1995 55 376 385 7529135
29. Modulation of tumor-induced lethality after pneumoperitoneum in a mouse model. Volz J, Volz-Koster S, Kanis S, Klee D, Ahlert C, Melchert F, Cancer 2000 89 262 266 10.1002/1097-0142(20000715)89:2<262::AID-CNCR9>3.0.CO;2-K 10918154 (Pubitemid 30489872)
30. Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum. van Rossen ME, Hofland LJ, van den Tol MP, van Koetsveld PM, Jeekel J, Marquet RL, van Eijck CH, J Pathol 2001 193 530 537 10.1002/1096-9896(2000)9999:9999<::AID-PATH805>3.0.CO;2-O 11276014 (Pubitemid 32266824)
31. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. van Grevenstein WM, Hofland LJ, van Rossen ME, van Koetsveld PM, Jeekel J, van Eijck CH, Dig Dis Sci 2007 52 2775 2783 10.1007/s10620-007-9778-4 17394066 (Pubitemid 47373923)
32. Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor. Malik ST, East N, Boraschi D, Balkwill FR, Br J Cancer 1992 65 661 666 10.1038/bjc.1992.141 1586593
33. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. Singh H, Sachan R, Goel H, Mittal B, BJOG 2008 115 633 638 10.1111/j.1471-0528.2007.01655.x 18333945 (Pubitemid 351357571)
34. The TNF-alpha, IL-1βB and IL-1β0 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. Yang Y, Luo C, Feng R, Bi S, J Cancer Res Clin Oncol 2011 137 947 952 10.1007/s00432-010-0959-8 21107607